Threshold of Clinical Severity of Cervical Dystonia for Positive 18F-FDG PET/CT
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective To examine whether the clinical severity of cervical dystonia (CD) significantly correlates with 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) findings as well as to determine the threshold of the clinical severity of CD for positive 18F-FDG PET/CT study findings.Methods Forty-seven subjects with torticollis as one of the symptoms of CD were included. The clinical severity of CD was evaluated with the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) at the time of 18F-FDG PET/CT. The correlation between the clinical severity of CD and the highest SUVmax was examined. The threshold of the clinical severity of CD necessary for positive 18F-FDG PET/CT findings was determined using receiver operating characteristics curve analysis.Results Thirty-three of the 47 subjects (70.21%) showed positive 18F-FDG PET/CT findings. The ipsilateral splenius capitis/cervicis, oblique capitis inferior, and longus colli/capitis were the rotators most frequently involved. The highest SUVmax of 18F-FDG PET/CT was significant correlated with the TWSTRS. Subjects with a total TWSTRS exceeding 39 showed positive 18F-FDG PET/CT findings, with those having a total TWSTRS ≤22 showing negative 18F-FDG PET/CT results. The cutoff value of the total TWSTRS for positive 18F-FDG PET/CT findings was set at 27.5 with 90.9% sensitivity and 64.3% specificity.Conclusion A significant correlation was evident between the clinical severity of CD and 18F-FDG PET/CT findings, providing a threshold of the clinical severity of CD for acquisition of positive 18F-FDG PET/CT findings.
Abstract
Objective To examine whether the clinical severity of cervical dystonia (CD) significantly correlates with 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) findings as well as to determine the threshold of the clinical severity of CD for positive 18F-FDG PET/CT study findings.Methods Forty-seven subjects with torticollis as one of the symptoms of CD were included. The clinical severity of CD was evaluated with the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) at the time of 18F-FDG PET/CT. The correlation between the clinical severity of CD and the highest SUVmax was examined. The threshold of the clinical severity of CD necessary for positive 18F-FDG PET/CT findings was determined using receiver operating characteristics curve analysis.Results Thirty-three of the 47 subjects (70.21%) showed positive 18F-FDG PET/CT findings. The ipsilateral splenius capitis/cervicis, oblique capitis inferior, and longus colli/capitis were the rotators most frequently involved. The highest SUVmax of 18F-FDG PET/CT was significant correlated with the TWSTRS. Subjects with a total TWSTRS exceeding 39 showed positive 18F-FDG PET/CT findings, with those having a total TWSTRS ≤22 showing negative 18F-FDG PET/CT results. The cutoff value of the total TWSTRS for positive 18F-FDG PET/CT findings was set at 27.5 with 90.9% sensitivity and 64.3% specificity.Conclusion A significant correlation was evident between the clinical severity of CD and 18F-FDG PET/CT findings, providing a threshold of the clinical severity of CD for acquisition of positive 18F-FDG PET/CT findings.
참고문헌 (22)
- Jankovic J., "Parkinson’s disease and movement disorders, 5th ed" (2007), Lippincott Williams & Wilkins
- Jankovic J., "Prevalence of cervical dystonia and spasmodic torticollis in the United States general population", Parkinsonism Relat Disord, 13, pp.411~416 (2007)
- Epidemiological Study of Dystonia in Europe(ESDE)Collaborative Group., "A prevalence study of primary dystonia in eight European countries", J Neurol, 247, pp.787~792 (2000)
- Camargo CH., "Cervical dystonia : clinical and therapeutic features in 85 patients", Arq Neuropsiquiatr, 66, pp.15~21 (2008)
- Albanese A., "A systematic review on the diagnosis and treatment of primary(idiopathic)dystonia and dystonia plus syndromes : report of an EFNS", MDS-ES Task Force, 2006, pp.13, 433~444
- Brans JW., "Botulinum toxin in cervical dystonia : low dosage with electromyographic guidance", J Neurol, 242, pp.529~534 (1995)
- Comella CL., "Botulinum toxin injection for spasmodic torticollis : increased magnitude of benefit with electromyographic assistance", Neurology, 42, pp.878~882 (1992)
- Anderson TJ., "Botulinum toxin treatment of spasmodic torticollis", J R Soc Med, 85, pp.524~529 (1992)
- Truong D., "Efficacy and safety of botulinum type A toxin(Dysport)in cervical dystonia : results of the first US randomized, double-blind, placebocontrolled study", Mov Disord, 20, pp.783~791 (2005)
- Jankovic J., "Treatment of cervical dystonia with botulinum toxin", Mov Disord, 19(Suppl 8), pp.S109~S115 (2004)
- Brans JW., "Electromyography in cervical dystonia : changes after botulinum and trihexyphenidyl", Neurology, 51, pp.815~819 (1998)
- Sung DH., "Localization of dystonic muscles with 18F-FDG PET", CT in idiopathic cervical dystonia, 2007, pp.48, 1790~1795
- Han Byul Lee, "Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography", Computed Tomography in Management of Cervical Dystonia, 2012, pp.36(6), 745~755[DOI]
- 임신영, "사경의 감별 진단 및 치료", 대한의사협회지, 52(7), pp.705~718 (2009), 대한의사협회
- Consky ES., "Clinical assessments of patients with cervical dystonia", Neurol Dis Ther, 25, pp.211~ (1994)
- Salvia P., "Clinical and goniometric evaluation of patients with spasmodic torticollis", Clin Biomech (Bristol, Avon), 21, pp.323~329 (2006)
- 안영실, "Nonionic intravenous contrast agent does not cause clinically significant artifacts to F-18-FDG PET", CT in patients with lung cancer, 2007, pp.21, 585~592[DOI]
- An YS., "Diagnostic performance of(18)F-FDG PET", CT for lymph node staging in patients with operable nonsmall-cell lung cancer and inflammatory lung disease, 2008, pp.186, 327~336
- Lee IH., "Initial experience with imaging-guided intramuscular botulinum toxin injection in patients with idiopathic cervical dystonia", AJR Am J Roentgenol, 192, pp.996~1001 (2009)
- Jankovic J., "Cervical dystonia : clinical findings and associated movement disorders", Neurology, 41, pp.1088~1091 (1991)
- Brashear A., "Duration of effect of botulinum toxin type A in adult patients with cervical dystonia : a retrospective chart review", Clin Ther, 22, pp.1516~1524 (2000)
- Brashear A., "Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A", Mov Disord, 13, pp.158~161 (1998)